1,2-Dehydrogenation of 21-carbon steroids possessing an oxygen function at carbons 11, 17 and 21 (cortisone and cortisol) results in an enhancement of anti-anabolic or catabolic and anti-inflammatory properties in Addisonian subjects (2) . * Part of this material has been presented previously (1) . The names "metacortandracin" and "metacortandralone" have since been replaced by "prednisone" and "prednisolone." 3 
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METHOD
Balance studies were carried out on three normal subjects. The diet and fluid intake were kept constant. Stools were collected in six or eight day periods and urine in one day pools. Stools, diets and urine were analyzed for nitrogen (3), phosphorus (4), calcium (5), potassium and sodium (6) . Urine was also analyzed for 17,21-dihydroxycorticoids (phenylhydrazine-sulfuric acid chromogens) (7) and 17-ketosteroids (8) . Blood was drawn at appropriate intervals for the determination of circulating eosinophiles, serum sodium, potassium, carbon dioxide, calcium and phosphorus. Steroids were given orally or intramuscularly, one-quarter of the dose every six hours.
RESULTS
The results are shown graphically in Figures 1 through 11. During treatment with both the 1,4-diene steroids and the parent compounds the fecal excretion of nitrogen, phosphorus, calcium and potassium was generally less than that in the preceding control periods; after treatment it was generally much greater. The patients complained of constipation during treatment. The large fluctuations in apparent calcium and phosphorus balances resulting from this phenomenon (see, for example, Figures 1 and 2 ) render balance data relatively less reliable than urinary data for these elements.
I. Nitrogen metabolism
Prednisolone, in doses of 30 mg. a day, caused an increase in urinary nitrogen excretion and a slight negative nitrogen balance ( Figure 2 cretion and a negative nitrogen balance (Figures gen balance, prednisone and prednisolone, admin-2 and 3). The loss of nitrogen induced by 70 istered orally, appear from these studies to be mg. of the 1,4-diene steroids was considerably seven to eight times [parallel line assay method greater than that with the parent steroids, cortisol (9) ] as active as the parent steroids. The efand cortisone, at doses two to five times as large. fects on nitrogen metabolism of both types of Prednisone, in doses of 280 mg. a day, caused a steroids are quantitatively more pronounced in large increase in urinary nitrogen and a negative the Addisonian than in the normal subjects ( (Figure 2) . The slight apparent negative calcium balance with this medication did not differ from that found throughout these studies. Prednisone and prednisolone, in doses of 60 to 280 mg. a day, caused an increase of urinary calcium in five of the six periods studied (Figures 1 and 3 ) with return to control values in one day after oral medication and in two to three days after intramuscular medication. In the remaining period, urinary calcium fell during the treatment (Figure 2) . With cortisone and cortisol, in doses of 240 and 280 mg. a day, there was an increase in urinary calcium with a subsequent fall on withdrawal of medication (Figures 1 and 3) . With cortisol, at a dose of 150 mg. a day, urinary calcium did not change significantly (Figure 2) . With 9a-fluoroprednisolone and 9a-fluorocortisol, in doses of 3 mg. a day, there was a rise of urinary calcium (Figure 5 ).
IV. Potassium metabolism
Prednisone and prednisolone, in doses of 30 to 280 mg. a day, caused transient increases of urinary potassium, with negative balance, on the first day of treatment (Figures 6 through 8 ).
When treatment was discontinued, there was a transient decrease of urinary potassium, with positive balance, for one to three days. The same changes occurred with cortisone and cortisol in doses of 150 to 280 mg. a day (Figures 6 through  8) . In no instance were the changes in potassium balance accompanied by commensurate changes in nitrogen balance: They occurred even when there were no reciprocal changes in sodium balance.
9a-Fluoroprednisolone and 9a-cortisol, in doses of 3 mg. a day, caused similar marked transient increases of urinary potassium, with negative balance, on the first day of treatment (Figure 9 ). On the fourth subsequent day there occurred a second rise in the urinary potassium, with negative balance, which persisted until withdrawal of treatment: The serum potassium fell markedly with both steroids. A prompt decrease of urinary potassium, with positive balance, occurred when treatment was discontinued. These latter periods of negative and positive balance were associated with reciprocal changes in sodium balance (vide infra (Figures 6 and 8 ).
The effect of doubling the sodium intake on the response to 280 mg. of prednisone is shown in Figure 8 . On the higher sodium intake the early retention and the late loss of sodium were quantitatively much greater. Cortisone and cortisol, in doses of 150 and 280 mg. a day, produced quantitatively much greater retention of sodium and allowed relatively little "escape" during therapy (Figures 6 and 8) .
9a-Fluoroprednisolone and 9a-fluorocortisol, in doses of 3 mg. a day, caused marked sodium re-,' tention ( Figure 9 ), which was accompanied (side supra) by potassium loss VII. Theoretical weight curves "Theoretical" weight curves based on nitrogen, potassium and sodium balances are presented in Figures 8 and 9 . They show excellent correlation with the actual weight curves indicating that there were no unexplained shifts of fluid during these studies.
DISCUSSION
The loss of nitrogen produced by the 1,4-diene steroids and the parent compounds is shown in summary in Figure 4 . It is clear that the potency of prednisone and prednisolone, judged from their effects upon nitrogen metabolism, is considerably more than four times that of the parent compounds, the factor (12) estimated from anti-inflammatory effects in rheumatoid arthritis. Indeed, the mean ratio of potency of 1,4-diene to parent steroids based upon these studies on nitrogen metabolism is about eight. This is somewhat lower than the ratio (about 12) arrived at from studies on Addisonian patients (2) .
In spite of the fluctuations in apparent calcium balance previously alluded to (and ascribed to the constipating effect of the steriods), it is evident from the magnitude of the increases of urinary calcium seen with the 1,4-diene steroids at the higher doses that they represent loss of bone tissue.
The effect of these steroids on potassium metabolism appears to represent the summation of four independent phenomena. a) The transient loss of potassium on starting treatment, which precedes nitrogen loss and sodium retention, and the corresponding transient retention of potassium on stopping treatment, which precedes nitrogen retention and sodium loss (see, for example, Figure 8, Days 8 and 16, 40 and 48), has been attributed to the anti-inflammatory action of steroids (13) . b) When large losses of nitrogen were induced with the steroids, some loss of potassium also occurred (see, for example, Figure 6 , Days 30 to 33). However, in no instance was the magnitude of the loss commensurate (10) with that of nitrogen. This strongly suggests that c) potassium without nitrogen was stored during steroid administration. As noted above, a similar discrepancy appeared in the phosphorus balance, and both may be attributable to glycogen formation. Finally, d) with halogenated steroids, in doses too small to affect nitrogen balance, large losses of potassium were seen when sodium was being retained, and large gains of potassium were seen when sodium was lost after the steroids were discontinued (see, for example, Figure 9 ). This phenomenon appears to result from steroid-induced potentiation of sodium-potassium exchange at the renal tubular level (14, 15) .
This study confirms the impression gained from an earlier one (2) that the 1,4-diene steroids increase renal tubular sodium transport, as they produced transient sodium retention when given in large doses. The subsequent "escape," which we attribute to enhancement of glomerular filtration rate, occurred in all instances.
The suppression of adrenal cortical activity of the 1,4-diene steroids is apparent from the marked decrease in 17-ketosteroid excretion ( Figure 10 ). With cortisol, at two to five times the dose, only transient decrease of 17-ketosteroid excretion occurred. The difference appears to be the resultant of two phenomena. At the doses employed, both prednisolone and cortisol probably suppress adrenocorticotropic hormone (ACTH) secretion equally effectively. Consequently, secretion of adrenal 19-carbon steroids, as well as that of 21-carbon steroids destined for degradation to 19-carbon steroids, is suppressed. The urinary 17-ketosteroids during therapy (in this female subject) presumably represent degradation products of the administered steroid. The low figures observed with the 1,4-diene steroids result both from the enhanced ability of these steroids to suppress the adrenal cortex and from their limited conversion to 17-ketosteroids, as compared to the parent steroids (16) . The latter phenomenon is illustrated in Figure 11 , which shows studies in a female Addisonian subject lacking endogenous sources of 17-ketosteroids. 
